Analyze Diet
American journal of veterinary research2001; 62(9); 1365-1369; doi: 10.2460/ajvr.2001.62.1365

Reactivity of serum samples of dogs and horses tested by use of class-specific recombinant-based enzyme-linked immunosorbent assays for detection of granulocytic ehrlichiosis.

Abstract: To test serum samples of dogs and horses by use of class-specific recombinant-based ELISA for establishing a diagnosis of granulocytic ehrlichiosis attributable to infection with organisms from the Ehrlichia phagocytophila genogroup. Methods: Serum samples from 43 client-owned dogs and 131 horses (81 with signs of acute illness and 50 without signs of disease). Methods: Serum samples were analyzed, using ELISA with a recombinant 44-kd protein antigen for IgM and IgG antibodies to the human granulocytic ehrlichiosis (HGE) agent (NCH-1 strain). Western blot analyses, using infected human promyelocytic leukemia cells, were conducted on 38 serum samples of horses and 11 serum samples of dogs to verify reactivity to the 44-kd peptide. Results: IgM or IgG antibodies to the HGE agent were detected in 5 to 28% of dog serum samples and 5 to 37% of horse serum samples. Thirty-five of 38 (92%) horse serum samples had corresponding results on both tests (2 positive results for 26 samples and 2 negative results for 9 samples), using an ELISA for IgG antibodies or immunoblotting for total immunoglobulins. All 11 serum samples of dogs had positive results for both methods. Conclusions: These ELISA with recombinant 44-kd antigen are suitable for detecting IgM or IgG antibodies to the HGE agent in serum samples of dogs and horses. Positive results for serum samples of horses from Connecticut, New York, Virginia, and Georgia indicate that the HGE agent is widely distributed in tick-infested areas of the eastern United States.
Publication Date: 2001-09-19 PubMed ID: 11560261DOI: 10.2460/ajvr.2001.62.1365Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Comparative Study
  • Journal Article
  • Research Support
  • Non-U.S. Gov't
  • Research Support
  • U.S. Gov't
  • Non-P.H.S.
  • Research Support
  • U.S. Gov't
  • P.H.S.

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research paper investigates the usefulness of a specific method (using an enzyme-linked immunosorbent assay or ELISA) for detecting a disease known as granulocytic ehrlichiosis in dogs and horses, caused by infection with organisms from the Ehrlichia phagocytophila genogroup. The researchers found that the ELISA method reliably detected antibodies for the disease in the serum samples of both dogs and horses.

Methodology in the Study

  • The researchers analyzed serum samples that were collected from 43 dogs and 131 horses, with the horses being a mixture of those displaying signs of acute illness and those appearing healthy.
  • The enzyme-linked immunosorbent assay (ELISA) method, which utilizes a recombinant 44-kd protein antigen, was used to examine the samples for IgM and IgG antibodies associated with the granulocytic ehrlichiosis disease. This specific disease is caused by organisms from the Ehrlichia phagocytophila genogroup.
  • Western blot analyses, a laboratory method used for detection of proteins, were also carried out on a subset of the samples to verify the ELISA test’s reactivity to the antigen.

Results of the Study

  • The ELISA method was able to detect granulocytic ehrlichiosis antibodies in a significant number of both dog and horse samples. Specifically, 5 to 28% of dog samples and 5 to 37% of horse samples tested positive for either IgM or IgG antibodies.
  • Of the horse samples that were subjected to both ELISA assay and Western blot analysis, 92% showed consistent results across both methods.
  • All dog samples that underwent both testing methods showed positive results, providing additional validation for the ELISA method using the 44-kd antigen.

Conclusion and Implications

  • The findings suggest that the ELISA method with the recombinant 44-kd protein antigen is suitable for use in detecting granulocytic ehrlichiosis in serum samples from dogs and horses.
  • Given the positive results for horse samples from Connecticut, New York, Virginia, and Georgia, it also lends support to the notion that the disease is likely to be widely distributed in tick-infested areas across the eastern United States.

Cite This Article

APA
Magnarelli LA, Ijdo JW, Van Andel AE, Wu C, Oliver JH, Fikrig E. (2001). Reactivity of serum samples of dogs and horses tested by use of class-specific recombinant-based enzyme-linked immunosorbent assays for detection of granulocytic ehrlichiosis. Am J Vet Res, 62(9), 1365-1369. https://doi.org/10.2460/ajvr.2001.62.1365

Publication

ISSN: 0002-9645
NlmUniqueID: 0375011
Country: United States
Language: English
Volume: 62
Issue: 9
Pages: 1365-1369

Researcher Affiliations

Magnarelli, L A
  • Department of Entomology, Connecticut Agricultural Experiment Station, New Haven 06504, USA.
Ijdo, J W
    Van Andel, A E
      Wu, C
        Oliver, J H
          Fikrig, E

            MeSH Terms

            • Animals
            • Antibodies, Bacterial / blood
            • Blotting, Western / veterinary
            • Connecticut
            • Dog Diseases / blood
            • Dog Diseases / immunology
            • Dog Diseases / microbiology
            • Dogs
            • Ehrlichia / growth & development
            • Ehrlichia / immunology
            • Ehrlichiosis / blood
            • Ehrlichiosis / immunology
            • Ehrlichiosis / microbiology
            • Ehrlichiosis / veterinary
            • Enzyme-Linked Immunosorbent Assay / methods
            • Enzyme-Linked Immunosorbent Assay / veterinary
            • Fluorescent Antibody Technique, Indirect / veterinary
            • Georgia
            • Horse Diseases / blood
            • Horse Diseases / immunology
            • Horse Diseases / microbiology
            • Horses
            • Humans
            • Immunoglobulin G / blood
            • Immunoglobulin M / blood
            • New York
            • Recombinant Proteins
            • Virginia

            Grant Funding

            • HR8/CCH113382-01 / NHLBI NIH HHS
            • R01-AI41440 / NIAID NIH HHS
            • U50/CCU111188-01 / PHS HHS

            Citations

            This article has been cited 0 times.